Navigating the complexity of colorectal liver metastasis: molecular profiling and tumor sidedness.
作者信息
Jo Sung Jun, Kim Jongman
机构信息
Department of Surgery, CHA Bundang Medical Center, Seongnam, South Korea.
Department of Surgery, Samsung Medical Center, Seoul, South Korea.
出版信息
Hepatobiliary Surg Nutr. 2025 Aug 1;14(4):700-702. doi: 10.21037/hbsn-2025-259. Epub 2025 Jul 25.
Abstract
摘要
相似文献
1
Navigating the complexity of colorectal liver metastasis: molecular profiling and tumor sidedness.
Hepatobiliary Surg Nutr. 2025 Aug 1;14(4):700-702. doi: 10.21037/hbsn-2025-259. Epub 2025 Jul 25.
2
Clinical and molecular heterogeneity associated with tumor sidedness in colorectal liver metastasis: a multicenter propensity cohort study.
Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):214-228. doi: 10.21037/hbsn-22-285. Epub 2023 Mar 22.
3
Predictive value of preoperative circulating tumor cells combined with hematological indexes for liver metastasis after radical resection of colorectal cancer.
Medicine (Baltimore). 2025 Jan 10;104(2):e41264. doi: 10.1097/MD.0000000000041264.
4
Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53.
J Cancer Res Clin Oncol. 2016 May;142(5):927-35. doi: 10.1007/s00432-015-2102-3. Epub 2015 Dec 31.
5
RUNX1/SLAMF3 Axis Drives Immunosuppression to Contribute to Colorectal Cancer Liver Metastasis by Blocking Phagocytosis and Depleting C1QC Tumor-Associated Macrophages.
Adv Sci (Weinh). 2025 Aug;12(32):e06641. doi: 10.1002/advs.202506641. Epub 2025 May 31.
6
Long chain fatty acid transport via SLC27A1 enhances DAG-3-P synthesis and accelerates colorectal cancer metastasis.
Sci Rep. 2025 Aug 29;15(1):31937. doi: 10.1038/s41598-025-17143-6.
7
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial.
JAMA Oncol. 2023 Sep 1;9(9):1245-1254. doi: 10.1001/jamaoncol.2023.2535.
8
The challenge of disappearing colorectal liver metastasis: balancing considerations between tumor biology and clinical consequence for liver surgery.
Clin Exp Metastasis. 2025 Jul 12;42(4):39. doi: 10.1007/s10585-025-10357-y.
9
LINC01106 stimulates growth and metastasis of colorectal carcinoma by sponging miR-744-5p.
Pak J Pharm Sci. 2025 Jul-Aug;38(4):1378-1388. doi: 10.36721/PJPS.2025.38.4.REG.13786.1.
10
The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancer.
J Cancer Res Clin Oncol. 2004 Sep;130(9):521-6. doi: 10.1007/s00432-004-0563-x. Epub 2004 May 6.
本文引用的文献
1
Unraveling the Interplay of KRAS, NRAS, BRAF, and Micro-Satellite Instability in Non-Metastatic Colon Cancer: A Systematic Review.
Diagnostics (Basel). 2024 May 12;14(10):1001. doi: 10.3390/diagnostics14101001.
2
Clinical and molecular heterogeneity associated with tumor sidedness in colorectal liver metastasis: a multicenter propensity cohort study.
Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):214-228. doi: 10.21037/hbsn-22-285. Epub 2023 Mar 22.
3
Liver Transplantation for Hepatic Metastases from Colorectal Cancer: Current Knowledge and Open Issues.
Cancers (Basel). 2023 Jan 5;15(2):345. doi: 10.3390/cancers15020345.
4
Histopathological Growth Pattern in Colorectal Liver Metastasis and The Tumor Immune Microenvironment.
Cancers (Basel). 2022 Dec 28;15(1):181. doi: 10.3390/cancers15010181.
5
Is Laterality Prognostic in Resected KRAS-Mutated Colorectal Liver Metastases? A Systematic Review and Meta-Analysis.
Cancers (Basel). 2022 Feb 4;14(3):799. doi: 10.3390/cancers14030799.
6
Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore.
J Pathol Clin Res. 2021 Jan;7(1):27-41. doi: 10.1002/cjp2.178. Epub 2020 Sep 9.
7
Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases.
Br J Surg. 2019 Dec;106(13):1747-1760. doi: 10.1002/bjs.11289. Epub 2019 Aug 6.
8
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.
Br J Cancer. 2015 Jun 9;112(12):1921-8. doi: 10.1038/bjc.2015.142. Epub 2015 May 5.
Zotero 插件